Literature DB >> 11313764

Parental origin of de novo MECP2 mutations in Rett syndrome.

M Girard1, P Couvert, A Carrié, M Tardieu, J Chelly, C Beldjord, T Bienvenu.   

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder occurring almost exclusively in females as sporadic cases. Recently, DNA mutations in the MECP2 gene have been detected in approximately 70% of patients with RTT. To explain the sex-limited expression of RTT, it has been suggested that de novo X-linked mutations occur exclusively in male germ cells resulting therefore only in affected daughters. To test this hypothesis, we have analysed 19 families with RTT syndrome due to MECP2 molecular defects. In seven informative families we have found by DHPLC a nucleotide variant which could be used to differentiate between the maternal and the paternal allele. In each subject investigated from these families, we have amplified specifically each allele and sequenced allele-specific PCR products to identify the allele bearing the mutation as well as the parental origin of each X chromosome. This approach allowed us to determine the parental origin of de novo mutations in all informative families. In five cases, the de novo MECP2 mutations have a paternal origin and in the two other cases a maternal origin. In all transitions at CpG, the de novo mutation observed was of paternal origin. The high frequency of male germ-line transmission of the mutation (71% of RTT informative cases) is consistent with a predominant occurrence of the disease in females.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313764     DOI: 10.1038/sj.ejhg.5200618

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

Review 1.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

2.  Novel double-deletion mutations of the OFD1 gene creating multiple novel transcripts.

Authors:  Takeshi Morisawa; Mariko Yagi; Agus Surono; Naoki Yokoyama; Makoto Ohmori; Hiroto Terashi; Masafumi Matsuo
Journal:  Hum Genet       Date:  2004-06-02       Impact factor: 4.132

Review 3.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

4.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.

Authors:  Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

5.  Substitution rate heterogeneity and the male mutation bias.

Authors:  Sofia Berlin; Mikael Brandström; Niclas Backström; Erik Axelsson; Nick G C Smith; Hans Ellegren
Journal:  J Mol Evol       Date:  2006-02-10       Impact factor: 2.395

6.  The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.

Authors:  Jeffrey L Neul; Timothy A Benke; Eric D Marsh; Steven A Skinner; Jonathan Merritt; David N Lieberman; Shannon Standridge; Timothy Feyma; Peter Heydemann; Sarika Peters; Robin Ryther; Mary Jones; Bernhard Suter; Walter E Kaufmann; Daniel G Glaze; Alan K Percy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-07       Impact factor: 3.568

Review 7.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

8.  Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome.

Authors:  D Hettiarachchi; N F Neththikumara; B A P S Pathirana; V H W Dissanayake
Journal:  J Autism Dev Disord       Date:  2020-01

Review 9.  The role of MeCP2 in brain development and neurodevelopmental disorders.

Authors:  Michael L Gonzales; Janine M LaSalle
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

Review 10.  De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention.

Authors:  Julie Gauthier; Guy A Rouleau
Journal:  Genome Med       Date:  2012-09-25       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.